2024-08-29
Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms
Viva Biotech will continue to strengthen the construction of its one-stop innovative novel drug R&D platform and manufacturing service platform.